At a glance
ClinicalIndex Comparison RecordN/ACompleted· 104 enrolled
Drug / intervention
Wavelight® Refractive Suite +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite
In Brief
A clinical study evaluating Wavelight® Refractive Suite and LASIK surgery for Refractive Error. Completed, enrolled 104 participants.
Detailed Summary
The purpose of this study is to evaluate outcomes of subjects undergoing myopic surgery using the WaveLight® Refractive Suite (Excimer EX500 and Femtosecond FS200 lasers).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Error
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedSep 2013
Primary CompletionJan 2014
Study CompletionAug 2014
TodayJul 2026
First PostedSep 13, 2013
Enrollment StartSep 1, 2013
Primary CompletionJan 1, 2014
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.8 years ago
Interventions
Wavelight® Refractive Suitedevice
Excimer EX500 and Femtosecond FS200 lasers (Wavelight® Refractive Suite) used during LASIK surgery for corneal flap creation and corneal ablation
LASIK surgeryprocedure
Surgical procedure for treating refractive error based on corneal reshaping